Champlain Investment Partners (FRPT) reports 3.6% Freshpet ownership in 13G
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Champlain Investment Partners, LLC filed a Schedule 13G reporting a passive ownership stake in Freshpet, Inc. common stock. As of the event date 12/31/2025, Champlain beneficially owned 1,776,396 shares, representing 3.6% of Freshpet’s outstanding common stock.
Champlain reported sole voting power over 1,669,976 shares and sole dispositive power over 1,776,396 shares, with no shared voting or dispositive power. The firm certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Freshpet.
Positive
- None.
Negative
- None.
FAQ
What stake in Freshpet (FRPT) does Champlain Investment Partners report?
Champlain Investment Partners reports beneficial ownership of 1,776,396 Freshpet common shares. This represents 3.6% of the company’s outstanding common stock as of the 12/31/2025 event date, according to the Schedule 13G filing.
Does Champlain Investment Partners seek control of Freshpet (FRPT) with this 13G filing?
Champlain states it does not seek to change or influence control of Freshpet. The firm certifies the shares were acquired and are held in the ordinary course of business, not in connection with any control-related transaction or campaign.
Why did Champlain Investment Partners file a Schedule 13G for Freshpet (FRPT)?
Champlain filed a Schedule 13G because it holds more than 5 percent at some point or crossed a reporting threshold and qualifies as a passive institutional investor. The filing reports its 3.6% beneficial ownership in Freshpet as of 12/31/2025.
Who signed the Freshpet (FRPT) Schedule 13G on behalf of Champlain?
The Schedule 13G was signed by Matthew Garcia, Chief Compliance Officer of Champlain Investment Partners. He certified, after reasonable inquiry, that the information reported about the Freshpet share ownership is true, complete, and correct.